ANDA 62500, held by Chartwell. Doxycycline Hyclate.
As of Nov 16, 2026, ANDA 62500 (Doxycycline Hyclate), held by Chartwell, was first approved by FDA on Sep 11, 1984, with 34 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline and other antibacterial drugs, doxycycline should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 11, 1984 | Original application | Approved | None posted |
| Doxycycline HyclateEQ 50MG BASE · capsule;oral | Doxycycline Hyclate | Rx |
| Doxycycline HyclateEQ 100MG BASE · capsule;oral | Doxycycline Hyclate | Rx |
| Mar 31, 2025 | Supplement 58Labeling · Standard review | Approved | None posted |
| Jul 21, 2021 | Supplement 56Labeling · Standard review | Approved | None posted |
| Jul 21, 2021 | Supplement 54Labeling · Standard review | Approved | None posted |
| Jul 21, 2021 | Supplement 52Labeling · Standard review | Approved | None posted |
| Dec 2, 2014 | Supplement 45Labeling · Standard review | Approved | None posted |
| Jun 30, 2008 | Supplement 42Labeling | Approved | None posted |
| Mar 28, 2006 | Supplement 38Labeling | Approved | None posted |
| Apr 26, 2005 | Supplement 30Labeling | Approved | None posted |
| Jul 27, 2004 | Supplement 29Labeling | Approved | None posted |
| Apr 11, 2002 | Supplement 25Labeling | Approved | None posted |
| Mar 12, 2002 | Supplement 24Manufacturing | Approved | None posted |
| Sep 12, 2001 | Supplement 23Manufacturing | Approved | None posted |
| Jul 26, 2000 | Supplement 22Labeling | Approved | None posted |
| Jul 26, 2000 | Supplement 21Manufacturing | Approved | None posted |
| Jan 28, 2000 | Supplement 20Manufacturing | Approved | None posted |
| Aug 20, 1999 | Supplement 19Manufacturing | Approved | None posted |
| Jul 23, 1999 | Supplement 18Manufacturing | Approved | None posted |
| Jul 23, 1999 | Supplement 17Manufacturing | Approved | None posted |
| Jul 23, 1999 | Supplement 16Manufacturing | Approved | None posted |
| Jul 23, 1999 | Supplement 15Manufacturing | Approved | None posted |
| Jul 23, 1999 | Supplement 14Manufacturing | Approved | None posted |
| Dec 9, 1998 | Supplement 13Manufacturing | Approved | None posted |
| May 30, 1997 | Supplement 12Manufacturing | Approved | None posted |
| Apr 18, 1997 | Supplement 11Manufacturing | Approved | None posted |
| Apr 18, 1997 | Supplement 10Manufacturing | Approved | None posted |
| Feb 13, 1996 | Supplement 9Manufacturing | Approved | None posted |
| Jan 13, 1994 | Supplement 8Labeling | Approved | None posted |
| Jun 22, 1993 | Supplement 6Manufacturing | Approved | None posted |
| Jun 9, 1993 | Supplement 7Labeling | Approved | None posted |
| Nov 3, 1992 | Supplement 5Labeling | Approved | None posted |
| Jun 19, 1992 | Supplement 4Manufacturing | Approved | None posted |
| Jun 19, 1992 | Supplement 3Manufacturing | Approved | None posted |
| Jun 19, 1992 | Supplement 2Manufacturing | Approved | None posted |
| Aug 22, 1991 | Supplement 1Labeling | Approved | None posted |
| Sep 11, 1984 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters